Mobile

A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given with Methotrexate in Subjects with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-004019-37

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to estimate the treatment effect of ABT-122 by measuring the percentage of subjects achieving American College of Rheumatology response rates (ACR20) at Week 12 and to assess the safety and tolerability of ABT-122 in subjects with active rheumatoid arthritis (RA).

Critère d'inclusion

  • Rheumatoid Arthritis

Liens